Streaming Research Spotlight: AmerisourceBergen
April 13, 2010 (FinancialWire) (Investrend Research Syndicate) — AmerisourceBergen Corp. (NYSE: ABC) is the focus of today’s commentary from market timer Frank Kollar (at http://www.financialwire.net/2010/04/13/amerisourcebergen-is-blue-chip-money-maker-according-to-kollar/) in which Kollar notes the company’s stock “just keeps rising, steady and with hardly ever so much as a dip, and has tacked on 113% in share value since March 2009.”
For those who may want to probe more deeply into the fundamentals of AmerisourceBergen, today’s Streaming Research Spotlight, courtesy of Stock Smart (http://www.investrend.stocksmart.com/) is available (at http://www.stocksmart.com/ri/toc?tid=&pc=ALL&nh=Y&sym=abc&caction=).
Investrend and Stock Smart both advise investors to exercise a reasonable degree of due diligence before trading in the equities of any public company, including carefully reading entire analyst reports and report disclosures, and then only in conjunction with advice from a registered financial advisor or broker. Investrend and the Stock Smart both further advise that any analyst rating, recommendation, target valuation, price target or opinion should be considered merely a portion of an investor’s total investigative process.
AmerisourceBergen Corporation, a pharmaceutical services company, provides drug distribution and related services to healthcare providers and pharmaceutical manufacturers in the United States, the United Kingdom, and Canada. The company was founded in 1985 and is headquartered in Valley Forge, Pennsylvania.
The Investrend Research Syndicate (http://www.investrend.com/research/syndicate), a proprietary entity of Investrend Communications, Inc., distributes reports published by sources dedicated to unbiased, reliable analytics and complete transparency. The primary measure for determining those sources is the “Standards for Independent Research Providers” (http://www.investrend.com/FIRST/standards).
FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).
FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.
[rsrchequty] [trmngnmrt] [stksmrtrmsrc] [hlthcrdp] [biomedphrm]